“Glutenostics Announces Partnerships with Major US Celiac Advocacy Groups”
LOS ANGELES, California (November 15, 2017)
Glutenostics LLC announced today new partnerships with Beyond Celiac and the Celiac Disease Foundation (CDF), trusted non-profit groups in the US for celiac disease. “By partnering with these outstanding organizations, we will work collaboratively to educate the celiac community about our novel at-home testing products, Gluten Detect, for monitoring compliance with the gluten-free diet,” stated David Winternheimer, PhD, CEO of Glutenostics LLC.
“For many patients with celiac disease, the emergence of almost any new or recurring symptom causes anxiety and distress. Patients often wonder if their discomfort is due to inadvertent gluten consumption or for other reasons,” stated Marilyn G. Geller, Chief Executive Officer of Celiac Disease Foundation. “Gluten Detect empowers patients to take charge, providing peace of mind that a gluten-free diet is being strictly followed, or indicating that further effort is needed to achieve compliance. Celiac Disease Foundation is proud to collaborate with Glutenostics on this critical endeavor.”
“Until now, people with celiac disease have largely been left to guesswork in confirming that they have accidentally ingested gluten. This is especially problematic for those newly diagnosed and for children who can’t always verbalize their symptoms,” says Alice Bast, CEO of Beyond Celiac. “When gluten exposure can trigger serious long-term health effects, it’s critical that our community has access to reliable tools that can help them manage the gluten-free diet, which can be incredibly burdensome for many within our community.”
Over the next year, Glutenostics will work closely with these groups to generate and disseminate focused informational and educational campaigns geared towards improving the monitoring of the gluten free diet, which is expected to improve the well-being of the celiac community. “With the assistance of these exceptional advocacy teams, we look forward to intimately engaging the celiac and gluten sensitivity communities, as well as anyone avoiding gluten in their diets, to help them live a healthier life,” noted Dr. Winternheimer. “We feel Gluten Detect is an essential and indispensable tool for these communities and are confident in the ability of Gluten Detect to empower people to take more control over their lives and make scientifically informed decisions concerning their diets.”
About Glutenostics LLC
Glutenostics was founded in 2016 with the mission of bringing new technologies to market that improve the livelihood of those living gluten-free, regardless of reason. In 2017, Glutenostics licensed their first technology from Biomedal (Seville, Spain), and developed their first product line, Gluten Detect, now available exclusively via their website www.glutendetect.us As Glutenostics continues to grow and expand, it continues to pursue partnerships with other technology innovators in the gluten-free and surrounding space to take their products into commercializing within the North American markets.
About Gluten Detect
Gluten Detect has not been evaluated by the FDA and is not intended to diagnose or treat any disease. Gluten Detect is for informational purposes only, allowing the user to determine if they have ingested gluten over the previous 1-2 days or more.
LOS ANGELES, Nov. 6th, 2017 /PRNewswire/ — Glutenostics LLC formally announced today the launch of their first product line, Gluten Detect, a rapid test suite for people on the gluten-free diet (GFD) to monitor compliance. In just 15 minutes or more, in the privacy of a bathroom anywhere in the world, people are now able to sample their urine or stool to detect gluten fragments indicative of gluten consumption over the previous 1-2 or more days. “This revolutionary and one-of-a-kind technology will empower people to take control of their gluten-free life and improve adherence to the diet through scientifically informed decision making,” states David Winternheimer, PhD, CEO of Glutenostics. “Whatever your motive for maintaining gluten-free living, Gluten Detect is a flexible monitoring tool to provide valuable insight into your dietary composition, and afford users peace of mind.”
The technology basis of Gluten Detect was developed by a company in Seville, Spain (Biomedal), where over a decade of research and development was invested in the innovation of these game-changing products. As an integral part of the worldwide roll-out of both lab- and home-based testing products for gluten, Glutenostics is responsible for the commercialization of these tests in the USA and Canada, where they are the exclusive licensee and distributor of the technology.
“Glutenostics is transforming the way people live gluten-free,” states Dr. Winternheimer, “both with these novel tests and assessment of future product opportunities in our pipeline.” In collaboration with industry-leading key opinion leaders and non-profit partners, Glutenostics is working to change the landscape of the gluten-free space. “Today we are also proud to announce our new investor, cited as the most successful biotech entrepreneur in Germany, Patrick Baeuerle. With our outstanding team of advisors, executives and partners, we are optimistic of Glutenostics’ ability to positively impact the gluten-free community.”
About Glutenostics LLC
Glutenostics was founded in 2016 with the mission of bringing new technologies to market that improve the livelihood of those living gluten-free, regardless of reason. In 2017, Glutenostics licensed their first technology from Biomedal (Seville, Spain), and developed their first product line, Gluten Detect, now available exclusively via their website www.glutendetect.us. As Glutenostics continues to grow and expand, it continues to pursue partnerships with other technology innovators in the gluten-free and surrounding space to commercialize those products in North America.
CHICAGO, Illinois (October 21, 2017)
Gluten Detect made its first North American pre-launch appearance today at the Food & Nutrition Conference & Expo (FNCE) in Chicago, Illinois. FNCE is organized by the National Academy of Nutrition and Dietetics, the nation’s largest professional organization for dietitians, and is celebrating its 100 th anniversary this year. “We are very excited to premiere Gluten Detect at this momentous event and milestone for the Academy,” commented Vassili Kotlov, head of marketing, “This new technology is a game-changing tool enabling the 3.5 million Americans on the gluten free diet to test themselves in the privacy of their own bathrooms to monitor their general compliance and identify transgressions.”
The Gluten Detect booth was buzzing with excitement and demonstrations at the opening event today in the exposition hall at McCormick Place West. “We anticipate a steady stream of enthusiastic dietary professionals over the next 3 days as we take this opportunity to educate the community on this revolutionary new test,” stated the company’s chief executive, Dr. David Winternheimer. “We encourage everyone on the gluten-free diet to visit our website to learn more and spread the word about this exciting new development for the gluten-free community.”
Gluten Detect is available exclusively for ordering online at www.glutendetect.us